Home Others Others Elsulfavirine

research use only

Elsulfavirine

Cat.No.S6200

Elsulfavirine (Elpida, VM-1500) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed for the treatment and prevention of HIV-1 infection.
Elsulfavirine Chemical Structure

Chemical Structure

Molecular Weight:

Jump to Mechanism of Action Chemical Information, Storage & Stability

Quality Control

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt) 3 years -20°C powder
CAS No. 868046-19-9 -- Storage of Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05204394 Unknown status
HIV-1-infection
Viriom
 April 1 2022 Phase 2|Phase 3
NCT05165550 Completed
HIV-1-infection
Viriom
 April 12 2022 Phase 1
NCT05163535 Completed
HIV-1-infection
Viriom
 January 19 2021 Phase 1|Phase 2
NCT05148754 Completed
Covid19|HIV-1-infection
Viriom
 January 23 2021 Phase 1
NCT03730311 Unknown status
HIV Infections
Viriom
 May 2019 Phase 1
NCT03706911 Completed
HIV-1-infection
Viriom
 January 21 2019 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.